Sign in
Not yet taking people in United StatesNo phase

Multi-Modal Digital Monitoring of Disease Symptoms in Spinocerebellar Ataxia

Key facts

Who runs it
BioSensics
Where
Lutherville and New York, United StatesSee the 2 sites
Trial code
Status
Not yet recruiting
People taking part
25 people, planned
Starts
15 Dec 2026
Expected to end
31 Jan 2029
Type of study
Observational
Record updated
1 October 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Male or female, aged 18-75 years
  • Fluent in English (able to speak and read)
  • Able to ambulate at least 10 meters independently or with a cane, without other assistive devices, as determined by the investigator
  • Able to independently perform all study activities safely, as determined by the investigator
  • Willing and able to provide informed consent and comply with all study procedures
  • Genetically or clinically confirmed diagnosis of spinocerebellar ataxia (SCA 1, 2, 3, or 6)

Who cannot take part

  • Individuals with a neurological, medical, or psychiatric condition (other than SCA) that, in the investigator's judgment, would interfere with safe participation in study activities or confound the assessment of ataxia
  • Any condition that, in the investigator's judgment, would prevent the participant from completing the study procedures safely
  • Individuals who are unable to ambulate at least 10 meters independently or with a cane
  • Pregnant individuals, due to potential changes in gait and physical activity during pregnancy

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Where in United States

  • Johns Hopkins University School of MedicineLutherville, United StatesContact: Ashley KucharskiNot yet recruiting
  • Columbia University Irving Medical Center/Neurological Institute of New YorkNew York, United StatesContact: Nadia AmokraneNot yet recruiting

About the trial

What the trial wants to find out

This is an observational study. Subjects with a documented diagnosis of spinocerebellar ataxia (SCA) will be screened and recruited to participate at two clinical sites: Johns Hopkins University (JHU) and Columbia University (CU).

Read full original descriptionShow less

Researchers at BioSensics, JHU, and CU will use wearable sensors computerized speech, psychomotor, and ocular assessments to evaluate the feasibility of using digital health technologies to monitor symptoms in SCA. Researchers will also measure the Scale for the Assessment and Rating of Ataxia (SARA) and other SCA clinical assessments.

The solution will be deployed for 25 participants with SCA for approximately 12 months with 5 study visits (Screening/Baseline, Day 1, Day 30, Day 90, Day 180, Day 360).

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Fit questions
Built from NCT07851376, who can take part
Record updated
1 October 2026